AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters

GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters

GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters

July 13, 2026 at 06:45 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

uk

Tags

clinical trial GSK jemperli mid-stage rectal cancer

All Coverage

GSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNenoySUd1c3Zqb25oTllmdm9NcjhBSVpZWUM0UVJ2bW5fUUFwdzRwNVc4cy1nSC1CRldNNFRiVlc1SjdBYmYxSGpBcFB0ZUUyLUc2VjI0UUt4aE1PY3FJSm4zQll2OUxuck1aajVtand0UUtQQ3NaVEFHdG5Oa0Z1WVhyM3dlVGxLdkdsSzNhbDYtaXpOb24zWEJ4cHVrRFdCLVFoaEhHMDFiSGF3TWZQOFhBVG1aQTdMYlNxYjlBY09NZ2I4TmJHTUo3Zw?oc=5" target="_blank">GSK's Jemperli meets main goal in mid-stage rectal cancer trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

US FDA advisers endorse Grail cancer test's benefits in key vote - Reuters

US FDA advisers endorse Grail cancer test's benefits in key vote Reuters

September 23, 2026 at 11:03 PM

Merck's drug for diabetes-related eye disease meets trial goal - Reuters

Merck's drug for diabetes-related eye disease meets trial goal Reuters

September 24, 2026 at 02:52 PM

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial - Reuters

Roche's obesity drug boosts blood sugar control, drives 15.5% weight loss in mid-stage trial Reuters

September 22, 2026 at 11:25 AM

Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal - reuters.com

Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal reuters.com

September 23, 2026 at 04:22 PM

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge - Reuters

Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge Reuters

September 22, 2026 at 08:10 PM

New hope for breast cancer patients as life-extending drug now on NHS in England

Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.

September 16, 2026 at 11:50 PM